Journal of Hepatology
Volume 46, Issue 3 , Pages 508-520 , March 2007

Immunological techniques in viral hepatitis

  • Barbara Rehermann

      Affiliations

    • Immunology Section, Liver Diseases Branch NIDDK, National Institutes of Health, DHHS, 10 Center Drive, Room 9B16, Bethesda, MD 20892, USA
    • Corresponding Author InformationCorresponding authors. Tel.: +1 301 402 7144; fax: +1 301 402 0491 (B. Rehermann), tel.: +44 20 7679 6512; fax: +44 20 7380 0405 (N.V. Naoumov).
    • ,
  • Nikolai V. Naoumov

      Affiliations

    • Institute of Hepatology, University College London, 69-75 Chenies Mews, London WC1E 6HX, UK
    • Corresponding Author InformationCorresponding authors. Tel.: +1 301 402 7144; fax: +1 301 402 0491 (B. Rehermann), tel.: +44 20 7679 6512; fax: +44 20 7380 0405 (N.V. Naoumov).

  • Image Result

    General considerations for immunological assays. The answers to the indicated questions reflect laboratory practices of “experts” (21 international laboratories including those of the speakers and mod

    General considerations for immunological assays. The answers to the indicated questions reflect laboratory practices of “experts” (21 international laboratories including those of the speakers and moderators polled prior to the conference) and those of 170 conference participants. The data in (c) reflect multiple answers per person.

  • Image Result
    Assays of choice to monitor immune and viral parameters during vaccine and antiviral trials. Conference participants were asked to rank the respective assays (a) and studied parameters (b) from highes

    Assays of choice to monitor immune and viral parameters during vaccine and antiviral trials. Conference participants were asked to rank the respective assays (a) and studied parameters (b) from highest to lowest priority.

  • Image Result
    Conditions for ELISpot and proliferation assays. The answers to the indicated questions reflect laboratory practices of “experts” (21 international laboratories including those of the speakers and mod

    Conditions for ELISpot and proliferation assays. The answers to the indicated questions reflect laboratory practices of “experts” (21 international laboratories including those of the speakers and moderators polled prior to the conference) and those of 170 conference participants.

PII: S0168-8278(07)00004-9

doi: 10.1016/j.jhep.2007.01.002

Journal of Hepatology
Volume 46, Issue 3 , Pages 508-520 , March 2007

Article Tools

* Image Usage & Resolution